Art

J-GLOBAL ID：201702228431068495   Reference number：17A1296112

Clinical Characteristics of Seven Patients with Lanthanum Phosphate Deposition in the Stomach

胃におけるリン酸ランタン沈着を伴う患者7人の臨床的特徴

Author (9)： Murakami Naoko (Department of Internal Medicine, Okayama Saiseikai General Hospital, Japan) ,  Yoshioka Masao (Department of Internal Medicine, Okayama Saiseikai General Hospital, Japan) ,  Iwamuro Masaya (Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan) ,  Iwamuro Masaya (Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan) ,  Nasu Junichirou (Department of Internal Medicine, Okayama Saiseikai General Hospital, Japan) ,  Nose Soichiro (Department of Anatomic Pathology, Okayama Saiseikai General Hospital, Japan) ,  Shiode Junji (Department of Internal Medicine, Okayama Saiseikai General Hospital, Japan) ,  Okada Hiroyuki (Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Japan) ,  Yamamoto Kazuhide (Department of Internal Medicine, Okayama Saiseikai General Hospital, Japan)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 56  Issue： 16  Page： 2089-2095(J-STAGE)  Publication year： 2017 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1296112&from=J-GLOBAL&jstjournalNo=U0033A") }}

Author keywords (3)： lanthanum carbonate ,  hyperphosphatemia ,  chronic kidney disease

JST classification (1)： Digestive system diseases  (GH03000W)

Reference (23)：

• 1. Delmez JA, Slatopolsky E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 19: 303-317, 1992.
• 2. Shigematsu T; Lanthanum Carbonate Research Group. One year efficacy and safety of lanthanum carbonate for hyperphosphatemia in Japanese chronic kidney disease patients undergoing hemodialysis. Ther Apher Dial 14: 12-19, 2010.
• 3. Tsuchida K, Nagai K, Yokota N, Minakuchi J, Kawashima S. Impact of lanthanum carbonate on prognosis of chronic hemodialysis patients: a retrospective cohort study (Kawashima Study). Ther Apher Dial 20: 142-148, 2016.
• 4. Cernaro V, Santoro D, Lacquaniti A, et al. Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide. Int J Nephrol Renovasc Dis 9: 11-19, 2016.
• 5. Giotta N, Marino AM. Pharmacoeconomic analysis: analysis of cost-effectiveness of lanthanum-carbonate (Lc) in uncontrolled hyperphosphatemia in dialysis. Value Health 18: A511, 2015.

Terms in the title (5)： 胃 ,  リン酸ランタン ,  沈着 ,  患者 ,  臨床